Anteris Technologies logo — Anteris Technologies is a structural heart company focused o...

Anteris Technologies

Anteris Technologies is a structural heart company focused on developing innovative & durable health solutions.

Founded 2006 United States Eagan, United States 120 employees Post Ipo Equity Total: $45.00M Biotechnology, Health Care

General Information

Company Name Anteris Technologies
Founded Year 2006
Location United States Eagan, United States +3
Employees 120
Industries Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when Anteris Technologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Anteris Technologies

Anteris Technologies is a structural heart company founded in 2006 with the slogan "Anteris Technologies is a structural heart company focused on developing innovative & durable health solutions." This company is focused on developing innovative solutions to the biggest challenges facing aortic stenosis patients and their physicians. Their DurAVR™ Transcatheter Heart Valve (THV) System is designed for younger patients who need a heart valve that will last their lifetime. The DurAVR™ THV is a unique, single-piece valve with a first-in-class biomimetic design that replicates the normal blood flow of a healthy human aortic valve. Anteris Technologies operates in the Biotechnology and Health Care industries and is headquartered in the United States. Their last investment was a $35.00M Post-IPO Equity investment on 09 February 2023, with investors including Perceptive Advisors and L1 Capital. The company is known by the ticker symbol $AVR on the ASX and is associated with hashtags such as DurAVR, ADAPT, structuralheart, TAVR, TAVI, and cardiology.

Taxonomy: structural heart, health solutions, aortic stenosis, DurAVR, Transcatheter Heart Valve, THV System, biomimetic design, cardiology, innovation, TAVR, TAVI, aortic valve, heart surgery, ASX: AVR

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 2
Investor Investor
09 Feb 2023
Post-IPO Debt •••••• 1
Investor
01 Oct 2017

Anteris Technologies Alternatives & Competitors

Anteris Technologies vs

Pioneering non-surgical heart valve replacement with breakthrough catheter-based technology.

Series C
Health Care, Health and Wellness
Anteris Technologies vs

Thubrikar Aortic Valve is a privately held medical device company on a mission to revolutionize the...

Angel
4 employees
Health Care, Medical Devices
Anteris Technologies vs
Novostia
Novostia Switzerland

Heart valves for life, for patients of any age, including children

Unknown
15 employees
Health Care, Medical Devices

FAQ About Anteris Technologies

Anteris Technologies is a structural heart company focused on developing innovative & durable health solutions.
Anteris Technologies was founded in 2006.
Anteris Technologies is headquartered in Eagan, United States.
Anteris Technologies operates in the following industries: Biotechnology, Health Care.
Anteris Technologies has approximately 120 employees.
Anteris Technologies has completed 2 funding rounds, raising a total of $45.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Anteris Technologies include CoreValve, Thubrikar Aortic Valve, Novostia, JenaValve Technology, Inc., Dr. C Raghu Cardiologist. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Anteris Technologies and CoreValve are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Anteris Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy